Mentions in the news

Huffington Post: A New Turning Point in the Fight Against HIV/AIDS

By | AIDS 2012, Health Policy, HIV/AIDS | No Comments
Sean Cahill and Kenneth Mayer, MD of The Fenway Institute discuss the U.S. Food and Drug Administration’s decision to approve the drug tenofovir disoproxil fumarate/emtricitabine (brand name Truvada) for use in preventing HIV infection in HIV-negative people: July 16, 2012 could be another major turning point in the fight against HIV/AIDS. Today the U.S. Food and Drug Administration approved a supplemental new drug application for the previously approved antiretroviral medication tenofovir disoproxil fumarate / emtricitabine (TDF-FTC), to reduce the risk of acquiring HIV by uninfected men and women by taking a pill a day before and after exposure (known as 
Read More

Fenway Health named “Leader in Healthcare Equality”

By | Fenway News, Health Care, LGBT Health | No Comments
Fenway Health was named a “Leader in Healthcare Equality” by The Human Rights Campaign (HRC) in their 2012 Healthcare Equality Index (HEI), which was released this morning. This category includes facilities that responded “yes” to all of the Core Four HEI criteria and have policies in place to protect their LGBT (lesbian, gay, bisexual and transgender) patients and employees from discrimination, ensure equal visitation access for same-sex couples and same-sex parents through explicitly inclusive policies and provide staff training on LGBT patient-centered care. Fenway is deeply committed to providing quality, culturally competent care to our LGBT patients and to fairness 
Read More

Sec. Sebelius mentions Fenway in remarks to LGBT health coalition

By | Health Policy, LGBT Health | No Comments
On October 17, Health and Human Services Secretary Kathleen Sebelius addressed the National Coalition for LGBT Health. Highlighting the current administration’s work on LGBT health issues, Secretary Sebelius also mentioned the HHS grant to the Fenway Institute for the creation of a LGBT health training and assistance center. But one thing we already know is that access to community-based providers who are knowledgeable and culturally competent is important for every community. That’s why we’re taking steps to give community health centers the tools to double their capacity and reach underserved communities. For example, last month our Health Resources and Services 
Read More

New York Times: Questions on PrEP

By | HIV/AIDS | One Comment
Last year, a groundbreaking study (for which the Fenway Institute served as one of two U.S. test sites) showed that taking HIV medicines before becoming infected (known as Pre-Exposure Prophylaxis, or PrEP) greatly reduced the risk of HIV transmission in men who have sex with men. The study, called iPrEx, showed that high-risk individuals who took a single daily tablet containing two widely used HIV medications experienced an average of 43.8 percent fewer HIV infections than those who took a placebo pill. But how and when to put these findings into practice isn’t entirely clear, as this New York Times 
Read More